Search

everythinglearnresearchcommunity

for

Search:↓

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Early hair loss may indicate prostate issues.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Corn silk extract helps reduce prostate enlargement symptoms.

Certain genetic variants increase the risk of aggressive prostate cancer.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

% free PSA and urinary markers help better identify prostate cancer.

OnabotulinumtoxinA is used to treat wrinkles, pain, sweating, hair loss, and more by temporarily paralyzing muscles and affecting pain pathways.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Dosing time affects finasteride's effectiveness and safety in rats.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

Analog 23 is a promising compound for prostate cancer treatment.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Early hair loss may indicate future prostate issues.

New Finasteride conjugate improves prostate treatment and vital signs in rats.